Burden of major cancer types in Almaty, Kazakhstan.
Almaty
Burden of disease
Disability-adjusted life years
Kazakhstan
Neoplasms
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 09 2024
04 09 2024
Historique:
received:
09
04
2024
accepted:
28
08
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
4
9
2024
Statut:
epublish
Résumé
Globally, cancer is the second leading cause of death, with a growing burden also observed in Kazakhstan. This study evaluates the burden of common cancers in Almaty, Kazakhstan's major city, from 2017 to 2021, utilizing data from the Information System of the Ministry of Health. In Kazakhstan, most common cancers among men include lung, stomach, and prostate cancer, while breast, cervical, and colorectal cancers are predominant among women. Employing measures like disability-adjusted life years (DALYs), we found that selected cancer types accounted for a total DALY burden of 25,016.60 in 2021, with mortality contributing more than disability (95.2% vs. 4.7%) with the ratio of non-fatal to fatal outcomes being 1.4 times higher in women than in men. The share of non-fatal burden (YLD) proportion within DALYs increased for almost all selected cancer types, except stomach and cervical cancer over the observed period in Almaty. Despite the overall increase in cancer burden observed during the time period, a downward trend in specific cancers suggests the efficacy of implemented cancer control strategies. Comparison with global trends highlights the significance of targeted interventions. This analysis underscores the need for continuous comprehensive cancer control strategies in Almaty and Kazakhstan, including vaccination against human papillomavirus, stomach cancer screening programs, and increased cancer awareness initiatives.
Identifiants
pubmed: 39232186
doi: 10.1038/s41598-024-71449-5
pii: 10.1038/s41598-024-71449-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20536Informations de copyright
© 2024. The Author(s).
Références
Bryant, J. H., Harrison, P. F. & Health, I. of M. (US) B. on I. World Development Report 1993: Investing in Health (1996).
World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2019. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
Sung, H., Ferlay, J. & Siegel, R. L. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer. J. Clin. 71, 209–249 (2021).
doi: 10.3322/caac.21660
pubmed: 33538338
Bray, F. et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029–3030 (2021).
doi: 10.1002/cncr.33587
pubmed: 34086348
World Health Organization. International Agency for Research on Cancer. Cancer Today. https://gco.iarc.fr/today/online-analysis-map
Global Burden of Disease Study 2019 (GBD 2019) Socio-Demographic Index (SDI) 1950–2019 | GHDx. https://ghdx.healthdata.org/record/ihme-data/gbd-2019-socio-demographic-index-sdi-1950-2019
Interactive dashboards - Agency for Strategic planning and reforms of the Republic of Kazakhstan Bureau of National statistics. https://stat.gov.kz/en/instuments/dashboards/28507/
Global Burden of Disease Study 2021 (GBD 2021) Fertility Estimates 1950–2021 and Forecasts 2022–2100 | GHDx. https://ghdx.healthdata.org/record/ihme-data/global-burden-disease-study-2021-gbd-2021-fertility-1950-2100
Ebrahimi, H. et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir. Med. 9, 1030–1049 (2021).
doi: 10.1016/S2213-2600(21)00164-8
Yan, X. X. et al. Estimating disability-adjusted life years for breast cancer and the impact of screening in female populations in China, 2015–2030: An exploratory prevalence-based analysis applying local weights. Popul. Health Metr. 20, 1–11 (2022).
doi: 10.1186/s12963-022-00296-1
Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 3, 524 (2017).
doi: 10.1001/jamaoncol.2016.5688
pubmed: 27918777
World Health Organization (WHO). Global health estimates: Leading causes of DALYs. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys (2024).
The Ministry of Health of the Republic of Kazakhstan. Indicators of the oncology service of the Republic of Kazakhstan, 2021. 2022 [cited 2023 Jul 18]; Available from: https://onco.kz/wp-content/uploads/2022/11/pokazateli_2021.pdf
Murray, C. et al. (eds) The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 8–10 (World Health Organization, 1996).
Murray, C. J. L. & Lopez, A. D. Progress and directions in refining the global burden of disease approach: A response to Williams. Health Econ. 9, 69–82 (2000).
doi: 10.1002/(SICI)1099-1050(200001)9:1<69::AID-HEC493>3.0.CO;2-I
pubmed: 10694761
Demographic Statistics of the Republic of Kazakhstan. https://stat.gov.kz/official/industry/61/statistic/6
Abbafati, C. et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1160–1203 (2020).
doi: 10.1016/S0140-6736(20)30977-6
Roth, G. A. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018).
doi: 10.1016/S0140-6736(18)32203-7
Mathers, C. et al. Global Health Estimates Technical Paper. http://www.who.int/gho/mortality_burden_disease/en/index.html (2000).
Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 5, 1749–1768 (2019).
doi: 10.1001/jamaoncol.2019.2996
pubmed: 31560378
pmcid: 6777271
Institute for Health Metrics and Evaluation, Global Health Data Exchange. GBD Results. https://vizhub.healthdata.org/gbd-results/
Rommel, A. et al. BURDEN 2020-Burden of disease in Germany at the national and regional level. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Internet] 61, 1159–1166. Available from: https://pubmed.ncbi.nlm.nih.gov/30083946/
Porst, M. et al. The burden of disease in Germany at the national and regional level: Results in terms of disability-adjusted life years (DALY) from the BURDEN 2020 Study. Dtsch. Arztebl. Int. 119, 785 (2022).
pubmed: 36350160
pmcid: 9902892
Vos, T. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743–800 (2015).
doi: 10.1016/S0140-6736(15)60692-4
Burden 2020—RKI [Internet]. [cited 2023 Dec 18]. Available from: https://www.daly.rki.de/
Scottish Burden of Disease. https://scotland.shinyapps.io/phs-local-trends-scottish-burden-diseases/
Dicker, D. et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 392, 1684–1735 (2018).
doi: 10.1016/S0140-6736(18)31891-9
Igissinov, N. et al. Trend in gastric cancer mortality in Kazakhstan. Asian Pac. J. Cancer Prev. 23, 3779 (2022).
doi: 10.31557/APJCP.2022.23.11.3779
pubmed: 36444591
pmcid: 9930978
Morgan, E. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. eClinicalMedicine 47, 101404 (2022).
doi: 10.1016/j.eclinm.2022.101404
pubmed: 35497064
pmcid: 9046108
Iwu, C. D. & Iwu-Jaja, C. J. Gastric cancer epidemiology: Current trend and future direction. Hygiene 3, 256–268 (2023).
doi: 10.3390/hygiene3030019
Zhang, X. et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: A meta-analysis and systematic review. Gastroenterology 155, 347-354.e9 (2018).
doi: 10.1053/j.gastro.2018.04.026
pubmed: 29723507
Glushkova, N. et al. Prevalence of smoking various tobacco types in the Kazakhstani adult population in 2021: A cross-sectional study. Int. J. Environ. Res. Public Health 20, 1509 (2023).
doi: 10.3390/ijerph20021509
pubmed: 36674264
pmcid: 9865649
Zhakhina, G. et al. Incidence, mortality and disability-adjusted life years of acute myocardial infarction in Kazakhstan: Data from unified national electronic healthcare system 2014–2019. Front. Cardiovasc. Med. 10, 1127320 (2023).
doi: 10.3389/fcvm.2023.1127320
pubmed: 37600059
pmcid: 10433224
Li, H. Y. et al. Global, regional and national burden of chronic obstructive pulmonary disease over a 30-year period: Estimates from the 1990 to 2019 Global Burden of Disease Study. Respirology 28, 29–36 (2023).
doi: 10.1111/resp.14349
pubmed: 36054068
Igissinov, N. S., Toguzbayeva, A. Y., Igissinova, G. S. & Bilyalova, Z. A. Evaluation changes in indicators of oncological service in breast cancer in Kazakhstan. Medicine 1–2, 16–20 (2020).
doi: 10.31082/1728-452X-2020-211-212-1-2-16-20
Shatkovskaya, O., Kaidarova, D., Dushimova, Z., Sagi, M. & Abdrakhmanov, R. Trends in incidence, molecular diagnostics, and treatment of patients with breast cancer in Kazakhstan, 2014–2019. Oncol. Radiol. Kazakhstana 62, 16–23 (2022).
doi: 10.52532/2663-4864-2021-4-62-16-23
Kaidarova, D., Zhylkaidarova, A., Dushimova, Z. & Bolatbekova, R. Screening for cervical cancer in Kazakhstan. J. Glob. Oncol. https://doi.org/10.1200/jgo.18.65600 (2018).
doi: 10.1200/jgo.18.65600
Kaidarova, D. et al. Implementation of HPV vaccination pilot project in Kazakhstan: Successes and challenges. J. Clin. Oncol. 37, e13056 (2019).
doi: 10.1200/JCO.2019.37.15_suppl.e13056
Kaidarova, D., Jumanov, A., Zhylkaidarova, A. & Shayakhmetova, D. Colorectal cancer screening results in the regions of Kazakhstan with different levels of cancer prevalence. J. Clin. Oncol. https://doi.org/10.1200/JCO.2022.40.4_suppl.062 (2022).
doi: 10.1200/JCO.2022.40.4_suppl.062
Umurzakov, K. T. et al. Epidemiological characteristics of male reproductive cancers in the Republic of Kazakhstan: Ten-year trends. Iran J. Public Health 51, 1807 (2022).
pubmed: 36249097
pmcid: 9546805
Civil Code of the Republic of Kazakhstan, https://adilet.zan.kz/rus/docs/K940001000_
Smailova, D. S. et al. Data analysis of a pilot screening program for the early detection of esophageal and gastric cancers: Retrospective study. Vestn. Ross. Akad. Meditsinskikh Nauk 74, 405–412 (2019).
doi: 10.15690/vramn1109
Taszhanov, R. et al. Evaluation changes in indicators of oncological service in gastric cancer in Kazakhstan. J. Med. https://doi.org/10.31082/1728-452X-2020-211-212-1-2-16-20 (2020).
doi: 10.31082/1728-452X-2020-211-212-1-2-16-20
Igissin, N. et al. Liver cancer incidence in Kazakhstan: Fifteen-year retrospective study. Asian Pac. J. Cancer Prev. 25, 1763–1775 (2024).
doi: 10.31557/APJCP.2024.25.5.1763
pubmed: 38809649
pmcid: 11318810
Mussina, D. S., Bekbolatova, M. A. & Kazizova, G. S. Estimation of efficiency of the national screening program on early detection of liver cancer in pavlodar region. https://doi.org/10.31082/1728-452X-2018-191-5-7-11 (2018).
Gorasso, V. et al. The non-fatal burden of cancer in Belgium, 2004–2019: A nationwide registry-based study. BMC Cancer 22, 58 (2022).
doi: 10.1186/s12885-021-09109-4
pubmed: 35026995
pmcid: 8756629